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The formation of atherosclerotic lesions is characterized by
invasion of vascular smooth muscle cells (VSMC) into the
tunica intima of the arterial wall and subsequently by in-
creased proliferation of VSMC, a process apparently re-
stricted to the intimal layer of blood vessels. Both events are
preceded by the pathological overexpression of several
growth factors, such as platelet-derived growth factor
(PDGF) which is a potent mitogen for VSMC and can induce
their chemotaxis. PDGF is generally not expressed in the nor-
mal artery but it is upregulated in atherosclerotic lesions. We
have previously shown that PDGF-BB specifically stimulates
proliferating VSMC to secrete a 340 kDa hyaluronic acid
(HA-340). Here, we present evidence regarding the biological
functions of this glycan. We observed that HA-340 inhibited
the PDGF-induced proliferation of human VSMC in a dose-
dependent manner and enhanced the PDGF-dependent in-
vasion of VSMC through a basement membrane barrier.
These effects were abolished following treatment of HA-340
with hyaluronidase. The effect of HA-340 on the PDGF-de-
pendent invasion of VSMC coincided with increased secre-
tion of the 72-kDa type IV collagenase by VSMC and was
completely blocked by GM6001, a hydroxamic acid inhibitor
of matrix metalloproteinases. HA-340 did not exert any che-
motactic potency, nor did it affect chemotaxis of VSMC along
a PDGF gradient. In human atheromatic aortas, we found
that HA-340 is expressed with a negative concentration gradi-
ent from the tunica media to the tunica intima and the athero-
matic plaque. Our findings suggest that HA-340 may be
linked to the pathogenesis of atherosclerosis, by modulating
VSMC proliferation and invasion.
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Introduction
In human arteries, vascular smooth muscle cells (VSMC) are
mainly located within the tunica media in a contractile state,
expressing differentiation specific genes that are important for
VSMC functions, such as regulation of vessel tone and blood
pressure (Munro and Cotran, 1988; Tyberg et al., 1990; Ross,
1993). Under pathological conditions, such as vessel injury or
atherosclerotic plaque development, VSMC become exposed to
certain growth factors and cytokines, such as platelet-derived
growth factor (PDGF), that induce a transformation from the
contractile to a synthetic state (Ross et al., 1990; Ross, 1991,
1993; Jawien et al., 1992). Only in the latter state, VSMC acquire
the ability to proliferate and accumulate within the intimal layer
of blood vessels under the influence of chemotaxis-inducing
growth factors. During migration, VSMC have been shown to
digest major extracellular barriers such as basement membranes
(BM), interstitial collagens, and proteoglycans (Sperti et al.,
1992; Pauly et al., 1994). This enzymatic breakdown of
extracellular matrix (ECM) components is mediated by the
tightly regulated activity of proteases (Quigley et al., 1990).
Within this group of proteases, the family of matrix metallopro-
teinases (MMPs) are essential for the digestion of ECM
components such as collagens, gelatins, or proteoglycans (Matri-
sian, 1990; Woessner, 1991). As shown earlier, VSMC in vivo and
in vitro predominantly secrete the 72 kDa type IV collagenase
(MMP-2) (Galis et al., 1994), the expression of which can be
stimulated by PDGF-BB (Roth et al., 1996a).
Extensive in vitro studies revealed that PDGF-BB stimulates
the proliferation of VSMC, endothelial cells and fibroblasts
(Majeski et al., 1990; Okazaki et al., 1992; Ross, 1993). However,
recent data suggest that this growth factor is only a weak mitogen
for VSMC in vivo (Ferns et al., 1991; Jawien et al., 1992; Jackson
et al., 1993) but it induces their invasion from the tunica media
into the tunica intima (Munro and Cotran, 1988; Ross, 1993). This
in vivo effect of PDGF may be attributed to the enhanced
expression of MMP-2 (Pauly et al., 1994; Roth et al., 1996a). We
have recently reported that PDGF-BB specifically stimulates
proliferating VSMC to secrete a 340 kDa hyaluronic acid
(HA-340) (Papakonstantinou et al., 1995). In order to assess the
biological functions of this glycan, we investigated its effects on
proliferation and motility of human VSMC. We show that
HA-340 significantly inhibits the PDGF-BB-induced VSMC
proliferation and enhances their invasion through basement
membrane (BM) along a PDGF-BB gradient by increasing the
secretion of MMP-2. We also demonstrate that HA-340 is
expressed with a negative concentration gradient from the tunica
media to the tunica intima and the atheromatic plaque in human
atheromatic aortas, indicating that HA-340 may modulate the
state of dedifferentiation of VSMC associated with atherogenesis.
Results
Time course of the PDGF-induced VSMC proliferation and
HA-340 secretion
We have previously shown that PDGF-BB stimulates proliferat-
ing VSMC to secrete HA-340. This glycan was isolated, purified
and characterized from the culture media of human pulmonary
VSMC which were collected at different time points (0, 12, 24,
36, 48, and 72 h) after pulse stimulation with PDGF-BB
(10 ng/ml), as described previously (Papakonstantinou et al.,
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Fig. 1. PDGF-induced HA-340 secretion in relation to PDGF-induced de
novo synthesis of DNA by human VSMC. Quiescent subconfluent VSMC
(80% cell density, starved for 48 h at 0.1% FCS) were stimulated with a
single pulse of PDGF-BB (10 ng/ml) in the presence of [3H]-thymidine and
incubated at 37C. The incorporation of the radioligand into newly
synthesized DNA and the secreted amounts of HA-340 were determined,
respectively, at the time points indicated. Unstimulated cells were used as
controls for each time point. Results are presented as percentage of
[3H]-thymidine incorporation or secretion of HA-340 over controls. Each
data point represents the mean ± SE of triplicate determinations from two
independent experiments performed using at least four different cell lines of
human primary VSMC.
1995). In brief, lipids were extracted from the culture media using
a mixture of chloroform/methanol, the organic solvents were
removed by centrifugation, and the resulting pellet was treated
extensively with pronase, DNase, and alkali borohydrate. The
total glycan mixture was then separated from the digestion
products by gel filtration as a single peak with 90% recovery.
Fractionation of the total glycans, performed by HPLC, revealed
a major glycan fraction with molecular mass of 340 kDa.
Enzymatic characterization using GAG-degrading enzymes
revealed that the 340 kDa fraction was susceptible only to
hyaluronidase. The amount of HA-340 secreted by human
pulmonary VSMC in the culture medium was determined by
measuring the uronic acid content of this fraction. In parallel, at
each time point, the mitogenic response of VSMC to PDGF was
assessed by incorporation of [3H]-thymidine. We observed that
the maximal proliferative response upon pulse stimulation with
PDGF occurred between 12 and 36 h with a subsequent plateau
phase, while the secretion of HA-340 increased linearly over the
investigated time period of 72 h (Figure 1).
Effect of HA-340 on the spontaneous and the
PDGF-BB-induced proliferation of VSMC
The addition of HA-340 (1 µg/ml) to quiescent, subconfluent
VSMC cultures (80% cell density, starved for 48 h at 0.1% FCS)
resulted after 36 h of incubation at 37C in ∼60% inhibition of the
spontaneous VSMC proliferation, as indicated by the incorpor-
ation of [3H]-thymidine (Figure 2A). Pulse stimulation with
PDGF-BB (10 ng/ml) induced, as expected, VSMC proliferation,
which was ∼600% after 36 h of incubation (Figure 2B). Under the
same conditions, HA-340 significantly inhibited the PDGF-in-
duced proliferation of human VSMC. Maximal inhibition of the
PDGF-induced VSMC proliferation was obtained at 1.0 µg/ml of
HA-340 (35 ± 6.5%; p < 0.001) (Figure 2B). The concentrations
of HA-340 used are within the effective concentration range at
Fig. 2. Effect of HA-340 on the spontaneous and the PDGF-induced VSMC
proliferation. Quiescent subconfluent VSMC (80% cell density, starved for 48 h
at 0.1% FCS) were preincubated with various concentrations of HA-340 for 2h
prior to the addition of [3H]-thymidine (0.5 µCi/ml) (A) or [3H]-thymidine (0.5
µCi/ml) plus PDGF-BB (10 ng/ml) (B). The effect of HA-340 on cell
proliferation was assessed after 36 h of further incubation by measuring the
incorporation of [3H]-thymidine into newly synthesized DNA. In either case,
the spontaneous incorporation of [3H]-thymidine (A) and the mitogen-activated
incorporation of [3H]-thymidine (B) was set to 100%. Each bar represents the
mean ± SE of triplicate determinations from three independent experiments
using at least four different primary VSMC lines. Student’s t-test (unpaired, two
sided) was used for statistical analysis; (*) indicates levels of statistical
significance: *, p < 0.02; ***, p < 0.001. Control, 0.1% FCS.
which HA-340 can be measured in the culture media of
PDGF-stimulated VSMC (Papakonstantinou et al., 1995).
Effect of HA-340 on the chemotaxis of VSMC
The chemotactic potency of HA-340 on VSMC was studied using
a Boyden chamber system equipped with cell permeable filter
membrane (pore size 8 µm). As expected, PDGF-BB (10 ng/ml)
was a strong chemoattractant, forcing human VSMC to migrate
through the filter membrane along its concentration gradient
(Figure 3). HA-340, when added to the lower chamber compart-
ment, did not elicit any chemotactic potency on human VSMC and
furthermore, could not modify chemotaxis of VSMC along an
existing PDGF gradient (Figure 3). Similarly, when HA-340 was
added to the upper compartment, it had no effect on VSMC
migration towards either PDGF or culture medium (data not shown).
Effect of HA-340 on the invasion of VSMC through
reconstituted BM
The effect of HA-340 on the spontaneous and the PDGF-induced
VSMC invasion was studied using the Boyden-chamber-system
described above for the chemotaxis experiments, modified so that
the filter membranes were precoated with reconstituted BM. As
expected, PDGF-BB (10 ng/ml), when added to the lower
compartment, caused a considerable increase in VSMC invasion,
which was set to 100% (Figure 4). HA-340 (1 µg/ml) did not affect
the spontaneous invasion of VSMC when added to the lower
compartment. However, HA-340 significantly enhanced the
PDGF-induced invasion of VSMC, in a dose-dependent manner,
when added in the upper compartment of the Boyden chamber
(Figure 4). At the highest concentration of HA-340 used (1 µg/ml),
the PDGF-induced invasion of VSMC was enhanced by 42 ± 5.7%
(p < 0.001). The above described effect of HA-340 on the
PDGF-induced invasion could not be observed when HA-340 was
added to the lower compartment together with PDGF (Figure 4).
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Fig. 3. Effect of HA-340 on the chemotaxis of VSMC. The effect of HA-340
on the spontaneous and the PDGF-induced chemotaxis of human primary
VSMC was assessed using a modified Boyden chamber cell culture system.
Cells (104/ml) were seeded into the upper compartment of the Boyden
chamber and brought to quiescence (0.1% FCS, 48 h). Stimuli where then
added to the lower compartment, as indicated. Chemotactic activity was
assessed 24 h after the addition of each stimulus, as described under
Materials and methods. PDGF-BB (10 ng/ml) -induced chemotaxis was
regarded as 100%. Each bar represents the mean ± SE of triplicate
determinations from two independent experiments using at least four
different primary VSMC lines. Student’s t-test (unpaired, two sided) was
used for statistical analysis. Control, 0.1% FCS.
Effects of HA-340 on the PDGF-induced VSMC proliferation
and invasion following hyaluronidase treatment
HA-340 was treated with Streptomyces hyaluronidase (0.25 units per
µg of HA-340), for 6 h at 60C and enzyme activity was stopped
by boiling for 5 min. Digestion of HA-340 completely abolished
both: (1) the inhibitory effect of HA-340 on the PDGF-induced
VSMC proliferation (Figure 5A) and (2) the stimulatory effect of
HA-340 on the PDGF-dependent invasion of VSMC across an
artificial BM (Figure 5B). Inactivated hyaluronidase (0.25 units,
boiled for 5 min) did not affect the spontaneous or the PDGF-in-
duced VSMC proliferation or invasion (data not shown). These
results indicate that the oligosaccharides produced by hyaluronidase
treatment of HA-340 do not retain the activity of the intact fraction.
Furthermore, our data exclude the possibility of any contaminants
copurified with HA-340 interfering with the effects attributed to this
glycan.
Effect of HA-340 on the secretion of MMP-2 by VSMC
We tested the possibility that the stimulatory effect of HA-340 on
the PDGF-dependent invasion of VSMC may be associated with
enhanced degradation of the BM barrier by MMPs. The effect of
HA-340 on the spontaneous and the PDGF-induced secretion of
MMPs by VSMC was studied using gelatin zymography analysis.
Unstimulated primary human VSMC (80% cell density, starved
for 48 h at 0.1% FCS) secreted in the culture medium gelatinase
activity with molecular mass corresponding to 72 kDa (Figure
6A, lane 1), indicating MMP-2 activity. The secretion of MMP-2
by VSMC could be significantly stimulated by PDGF-BB
(10 ng/ml) (Figure 6A, lane 2, and Figure 6C). HA-340 enhanced,
Fig. 4. Effect of HA-340 on the invasion of VSMC through an artificial BM.
The effect of HA-340 on the spontaneous or the PDGF-induced VSMC
invasion through a BM barrier was assessed using a Boyden-chamber system
containing a cell permeable filter membrane coated with reconstituted BM.
Cells (104/ml) were seeded into the upper compartment of the
Boyden-chamber and brought to quiescence (0.1% FCS, 48 h). Stimuli were
then added to the upper or lower compartment, as indicated. Invasion of
VSMC in the presence of PDGF-BB (10 ng/ml) alone into the lower
compartment was regarded as 100%. Each bar represents the mean ± SE of
triplicate determinations from three independent experiments using at least
four different primary VSMC lines. Student’s t-test (unpaired, two sided)
was used for statistical analysis; (*) indicates levels of statistical
significance: *, p < 0.02; ***, p < 0.001. Control, 0.1% FCS.
in a dose dependent manner, the spontaneous (Figure 6A, lanes
3 and 4; Figure 6B) and the PDGF-induced (Figure 6A, lanes 5
and 6; Figure 6C) secretion of MMP-2 by VSMC.
The effect of HA-340 on the PDGF-dependent invasion of
VSMC is inhibited by the hydroxamic acid GM6001
GM6001 was shown to be a specific inhibitor of MMPs
(Grobelny et al., 1992). Using gelatin zymography analysis we
confirmed that GM6001, at 10–6 M, inhibits completely the
activity of commercial, purified MMP-2 as well as VSMC-se-
creted MMP-2 (data not shown). The effect of GM6001 on
VSMC invasion was studied using the modified Boyden chamber
system, as described above. The stimulatory effect of HA-340 on
the PDGF-dependent invasion of VSMC through a reconstituted
BM towards PDGF-BB (10 ng/ml) (Figure 7Ac,7B), was
significantly inhibited by GM6001 (10–6 M) (Figure 7Ad) in a
dose dependent manner (Figure 7B), indicating that the effect of
HA-340 on VSMC invasion requires MMP-2 activity. At the
concentrations used, GM6001 did not affect VSMC viability, as
defined by trypan blue exclusion (data not shown). Furthermore,
VSMC growth determined by thymidine incorporation was
unaffected by GM6001 at concentrations 10–8 to 10–6 M (data not
shown). Thus, the inhibitory effect of GM6001 on HA-340-in-
duced VSMC invasion could not be attributed to nonspecific
cytotoxicity.
Differential distribution of HA-340 in the layers of human
aortas
To assess the in vivo expression of HA-340 in human aortas, we
separated the atheromatic plaque and the different layers (tunica
E.Papakonstantinou et al.
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Fig. 5. Effect of HA-340 hyaluronidase-digest on the PDGF-induced VSMC
proliferation and invasion. (A) Quiescent subconfluent VSMC (80% cell
density, starved for 48 h at 0.1% FCS) were preincubated for 2 h in the
presence of medium or HA-340 (1 µg/ml) or HA-340 (1 µg/ml) digested
with hyaluronidase (0.25 units, 6h at 60C). [3H]-thymidine (0.5 µCi/ml)
was then added to the culture medium and cells were stimulated with a
single pulse of PDGF-BB (10 ng/ml). Incorporation of the radioligand into
newly synthesized DNA was measured after 36 h of further incubation.
Incorporation of [3H]-thymidine in cells stimulated with PDGF alone was set
to 100%. (B) The effect of HA-340 hyaluronidase-digest on the
PDGF-induced VSMC invasion through a BM barrier was assessed as
described in caption to Figure 4. Each bar represents the mean ± SE of
triplicate determinations from three independent experiments using at least
four different primary VSMC lines. Student’s t-test (unpaired, two sided)
was used for statistical analysis; (*) indicates levels of statistical
significance: ***, p < 0.001. Control, 0.1% FCS.
Fig. 6. Effect of HA-340 on the expression of MMP-2 by human VSMC.
(A) Gelatin zymography analysis of the effects of HA-340 and PDGF on
the secretion of MMP-2 in the culture media of primary human VSMC
(80% cell density, starved for 48 h at 0.1% FCS). Lane 1, unstimulated
cells; lanes 2–7, cells in the presence of: PDGF-BB (10 ng/ml), lane 2;
HA-340 (0.1 µg/ml), lane 3; HA-340 (1.0 µg/ml), lane 4; PDGF (10 ng/ml)
+ HA-340 (0.1 µg/ml), lane 5; PDGF (10 ng/ml) + HA-340 (1.0 µg/ml),
lane 6; PDGF (10 ng/ml) + HA (1.0 µg/ml), lane 7. Purified human
MMP-2 was used as positive control, lane 8. HA was commercial available
HA (225 kDa, Sigma). (B) and (C) Quantitative analysis of zymograms (n
= 4) as that presented in Figure 6A, using a computer supported image
analysis program. Activity of MMP-2 in the culture media of unstimulated
cells (control) and of PDGF-stimulated cells was set to 100% in (B) and
(C), respectively. Each bar represents the mean ± SE from four different
zymograms using four different primary VSMC lines. Student’s t-test
(unpaired, two sided) was used for statistical analysis; (*) indicates levels
of statistical significance: *, p < 0.02; ***, p < 0.001.
adventitia, tunica media, tunica intima) of human atheromatic
aortas and determined the amount of HA-340 (µg glycan/g of
tissue) in each vessel compartment. We found that, among other
glycosaminoglycans (GAGs), HA is present as a single molecular
size species in all described layers of human aortas. Biochemical
characterization of the HA isolated from each layer revealed that
it has an average molecular weight similar to the previously
purified HA-340 from human VSMC (Papakonstantinou et al.,
1995). The human aorta HA-340 was differentially distributed
within the different layers of human aortas (Table I). The highest
concentration of HA-340 was found in the tunica media (124.2 ±
24 µg/g tissue) with a notable decline in the neighboring
compartments (tunica intima: 39.8 ± 6.8 µg/g tissue; tunica
adventitia: 30.9 ± 5.2 µg/g tissue). Within the atheromatic plaque,
the quantity of HA-340 (26.1 ± 3.9 µg/g tissue) was the lowest as
compared to the other aortic compartments.
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Table I. Distribution of HA-340 in the layers of atheromatic aortas
[A] Vessel compartment HA-340 (µg/g tissue; mean ± SD)
Atheromatic plaque 26.1 ± 3.9
Tunica intima 39.8 ± 6.8
Tunica media 124.2 ± 24.0
Tunica adventitia 30.9 ± 5.2
[B] Vessel compartment Tunica intima Tunica media Tunica adventitia
Atheromatic plaque 0.039 0.0025 0.027
Tunica intima — 0.0047 0.145
Tunica media 0.0047 — 0.003
[A], Quantitative analysis of HA-340 in isolated human aortic layers and in atheromatic plaques. Data represent mean ± SE of triplicate determinations from
four individuals. [B], p values: statistical analysis (Student’s t-test, unpaired) comparing the expression of HA-340 between different vessel layers and the
atheromatic plaque. p < 0.05 indicates statistically significant differences.
Discussion
GAGs are a group of complex macromolecules that are expressed
in a wide range of tissues and compose an essential part of the
ECM (Jackson et al., 1991; Knudson and Knudson, 1993). They
have been shown to play a pivotal role in the formation of the
ECM and thus directly contribute to the control of cell function
(Jackson et al., 1991; Scott, 1992; Knudson and Knudson, 1993).
For example, it has been shown that the interaction of free HA
with cells modulates cell proliferation and migration (Laurent and
Fraser, 1992). Furthermore, it has been shown that the initial
phase of the ECM remodelling that occurs during the develop-
ment of fibroproliferative lesions is characterized by elevated
amounts of HA which could facilitate biological processes, such
as cell migration (Riessen et al., 1996).
We have recently reported that PDGF-BB specifically stimu-
lates proliferating VSMC to secrete a 340 kDa HA (Papakons-
tantinou et al., 1995). The PDGF-induced secretion of HA-340
was restricted to VSMC, since neither fibroblasts, epithelial, or
endothelial cells upregulated the synthesis of HA-340 in response
to PDGF (Papakonstantinou et al., 1995). In the present study, we
demonstrated that HA-340 exerts a regulatory biological activity
on proliferation and invasion of human VSMC. We found that
synthesis and secretion of HA-340 is increased in proliferating
VSMC. This observation is in agreement with the enhanced
synthesis and secretion of HA into the pericellular microenviron-
ment of proliferating cells which is generally believed to facilitate
the process of mitosis and cell growth (Laurent and Fraser, 1992).
However, it has also been reported that when HA is added directly
to mitogen-activated cells, it exerts antiproliferative effects on
mesenchymal derived human cell types such as fibroblasts
(Laurent and Fraser, 1992; Bodo et al., 1993; Mast et al., 1993).
In our experiments, HA-340 significantly inhibited the PDGF-in-
duced thymidine incorporation in human VSMC. Since the
maximal PDGF-induced secretion of HA-340 that we observed
occurred with a considerable time lag, as compared to the phase
of maximal de novo DNA synthesis, we may conclude that
VSMC in culture increase the synthesis of HA-340 in a late stage
of the cell cycle and thereby mobilize antiproliferative mechan-
isms to counterbalance the effects of mitogenic growth factors.
One might hypothesize that, in a physiological environment, the
synthesis and release of HA-340 functions as a regulatory
mechanism to regain homeostasis and to counterbalance an
ongoing state of cell proliferation.
The available data regarding the impact of GAGs and
especially of HA on invasion of different human cell types, at
present, remains conflicting. Depending on the cell type used,
commercial HA has been reported to exert either a stimulatory
effect on the invasion of glioma cell lines (Koochekpour et al.,
1995) or an inhibitory effect on the invasion of macrophages
(Levesque et al., 1994). Here, we present evidence that HA-340
did not affect the PDGF-induced chemotaxis of VSMC, but it
significantly increased the PDGF-dependent invasion of VSMC
through an artificial BM, towards PDGF.
Both the inhibitory effect of HA-340 on the PDGF-induced
proliferation of VSMC and the stimulatory effect of HA-340 on
the PDGF-dependent invasion of VSMC across an artificial BM
were abolished following exhaustive digestion of HA-340 by
Streptomyces hyaluronidase. These data indicate that the ensuing
oligosaccharides do not retain the activity of the intact HA-340
preparation and furthermore exclude the possibility of interfer-
ence by any contaminants copurified with HA-340. It remains to
be clarified if the above described biological effects of HA-340
on VSMC are size dependent. Evidence in support of this theory
are: (1) the fact that commercial HA with molecular mass of 225
kDa was about four times less potent than HA-340 on the above
described biological effects on VSMC (unpublished observa-
tions) and (2) that the oligosaccharides produced after treatment
of HA-340 with hyaluronidase did not have any effect on the
PDGF-induced VSMC proliferation or invasion. The average
molecular mass of HA-340, as calculated using HPLC gel
filtration analysis, was 340 kDa but the fraction was spreading
from 250 to 380 kDa, which is in agreement with the inherent
polydispersity of HA preparations (Papakonstantinou et al.,
1995). It is possible that endogenous mechanisms exist where by
tightly controlled synthesis of HA species of particular molecular
mass is employed as means of regulating cellular responses.
The stimulatory effect of HA-340 on the PDGF-dependent
invasion of VSMC through an artificial BM appears to be
mediated via proteolytic degradation of the BM barrier, since we
observed that the enhanced invasion of VSMC in response to
HA-340 coincides with an increased secretion by VSMC of
MMP-2, which specifically degrades collagen type IV (Matri-
sian, 1990; Woessner, 1991), the major component of BM (van
der Rest and Garrone, 1991). This is supported by the fact that the
hydroxamic acid analog GM6001, which is a well characterized
and specific inhibitor of MMPs (Grobelny et al., 1992; Leppert
et al., 1995), inhibited the effect of HA-340 on VSMC invasion
E.Papakonstantinou et al.
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in a dose dependent manner. The HA-340-induced MMP-2
proteolytic activity was evident in PDGF-stimulated cells as well
as in unstimulated cells. In the latter case, although VSMC
secreted increased amounts of MMP-2, they did not invade
through the BM barrier due to the lack of a chemoattractant
stimulus.
The inhibitory effect of HA-340 on the PDGF-induced
proliferation of VSMC may be attributed to the binding of PDGF
by the glycan since it has been reported that GAGs, in particular
heparin, can bind to and sequester growth factors, such as PDGF
(Ross, 1993). This possibility and in fact the molecular mechan-
ism of action of HA-340 is currently being investigated.
However, based on the available evidence HA-340 does not
appear to act by binding to PDGF since (1) HA-340 could not
inhibit the PDGF-induced chemotaxis or invasion of VSMC
when added in the lower compartment of the Boyden chamber
together with PDGF and (2) the PDGF-induced secretion of
MMP-2 was further stimulated in the presence of HA-340.
HA is considered to be involved in some of the key events that
lead to the formation of atherosclerotic lesions (Jackson et al.,
1991) and changes in the expression pattern of HA during the
development of atherosclerosis have been observed compared to
nonatherosclerotic vessels (Wasty et al., 1993; Heickendorff et
al., 1994; Levesque et al., 1994). In this context, our observation
that HA-340 is expressed with a negative concentration gradient
from the tunica media to the tunica intima to the atheromatic
plaque in human atheromatic aortas is of great interest, particular-
ly if one takes into account the in vivo effect of PDGF on human
VSMC. Even though PDGF is an established in vitro mitogen,
studies with infused PDGF, as well as studies with anti-PDGF
antibodies, have shown that this molecule is only a weak mitogen
for VSMC in the media of injured arteries (Ferns et al., 1991;
Jawien et al., 1992; Jackson et al., 1993; reviewed by Schwartz
et al., 1995). This apparent discrepancy for the weak mitogenic
activity of PDGF in the media of arteries may be explained by our
observations that: (1) HA inhibits the PDGF-induced prolifer-
ation of VSMC and (2) HA is found in highest concentration in
the tunica media of the aorta.
During the progression of many vascular diseases, such as
atherosclerosis, VSMC undergo a transition from a quiescent and
differentiated state to a dedifferentiated, proliferating and motile
phenotype (Ross, 1993). Relating the differential distribution of
HA-340 in the human atheromatic aorta that we observed here
and the above described in vivo effects of PDGF on human
VSMC, one might postulate the following hypothesis. Vessel
injury at the endothelial cell layer results in the release of growth
factors, such as PDGF, which stimulates VSMC proliferation,
chemotaxis, and invasion. HA-340, depending on its concentra-
tion and probably on the molecular weight predisposes VSMC
and their microenvironment in a way that permits either the
invasive process towards the chemoattractants or the proliferative
process to be manifested. Thus, the relative abundance of HA-340
or related molecules in the tunica media functions to direct
VSMC towards dedifferentiation, but still enables them to move
in contractile locomotion and to rearrange their positions during
conditions like shear stress. Proliferative responses are inhibited,
although migratory responses are submitted and VSMC are
directed to migrate from the tunica media into the tunica intima
along chemoattractant gradients. In the tunica intima and
especially in the atheromatic plaque, the initially inhibitory signal
of HA-340 on VSMC proliferation is diminished and the
functional response of VSMC to PDGF is now directed towards
proliferation. In conclusion, the PDGF-induced synthesis and
secretion of HA-340 by VSMC and the ability of this glycan to
inhibit VSMC proliferation and enhance VSMC invasion may
represent a further example of the common concept, according to
which mitogen-induced changes in the composition of the ECM
serve as a key point of cell dedifferentiation (Lin and Bissell,
1993), which in the particular case may be linked to the
pathogenesis of atherosclerosis.
Materials and methods
Cell cultures and characterization of VSMC
Primary cultures of human pulmonary VSMC were established
as previously described (Nauck et al., 1997) and subcultured in
Dulbecco’s minimal essential medium (DMEM, Seromed/Fako-
la) supplemented with 15% colostrum (Chemie Brunschwig),
15% fetal bovine serum (Gibco AG), 20 mM HEPES, and 8 mM
l-glutamine (Seromed). Subconfluent cultures of human VSMC
were growth arrested by serum starvation (DMEM + 0.1% fetal
bovine serum, 0.1% colostrum, 20 mM HEPES, and 8 mM
L-glutamine) for 48 h, followed by stimulation with human
recombinant PDGF-BB (10 ng/ml, Gibco AG). VSMC were
characterized by immunohistochemistry using monoclonal anti-
bodies specific to human VSMC (Boehringer Mannheim) as
positive staining and monoclonal antibodies against factor VIII or
keratin as negative staining (Boehringer Mannheim), as described
earlier (Roth et al., 1996b; Nauck et al., 1997).
Biopsies of human aortas
Biopsies of human aortas (upper thoracic level and its adjacent
part of the aortic arch), from male adults (n = 4, age 30–35 years)
were obtained at autopsy within 6 h following death by accident
and were kindly provided by the Department of Forensic
Medicine, School of Medicine, Aristotle University of Thessa-
loniki, Greece. The medical history of the individuals was free
from diseases, such as hypertension and diabetes, but autopsy
revealed that there was significant plaque development in their
aorta. The atheromatic plaque was dissected away and the vessels
were separated in their respective layers: tunica intima (endothe-
lium and subendothelial layer), tunica media, and tunica adventi-
tia, weighed, and homogenized three times for 5 sec in 10 ml of
ice-cold 100 mM Tris-HCl, pH 8.0, also containing 1 mM CaCl2.
Fig. 7. (opposite) Effect of GM6001 on the HA-340-induced invasion of VSMC. Invasion of VSMC was assessed using a Boyden chamber system containing a
cell-permeable filter membrane coated with reconstituted BM. Cells were seeded into the upper compartment of the Boyden-chamber and brought to quiescence
(0.1% FCS, 48 h). Stimuli were then added to the upper or lower compartment, as indicated. Chambers were incubated for additional 24 h (37C, 5% CO2)
before the filters were removed. Cells adherent to the upper side were removed and cells on the lower side of the membranes were fixed with 0.1 ml of 4%
paraformaldehyde in PBS and stained with Hoechst dye for 2 min. Invasion was assessed by counting the cells that appeared on the lower side of the filters by
immunofluorescence microscopy. In all cases, three randomly selected areas (1 ×1 mm2) were counted per filter. (A) Immunofluorescent microscopy (field ×100):
(a) control/control; (b) control/PDGF; (c) HA-340/PDGF; (d) HA-340 + GM6001 (10–6 M)/PDGF. (B) Number of cells invaded to the lower side of the filter.
Each bar represents the mean ± SE of triplicate determinations from three independent experiments using at least four different primary VSMC lines. Student’s




Isolation and purification of HA-340
Total glycans were isolated and purified from cell culture medium
of VSMC after stimulation with PDGF-BB (10 ng/ml), or from
the above biopsy specimens, as previously described (Papakons-
tantinou et al., 1995). In brief, lipids were extracted with 4
volumes of 1:2 (volume/volume) chloroform/methanol as de-
scribed by Svennerholm and Fredman (1980), thereby inactivat-
ing all hydrolytic enzymes. The mixture was centrifuged at 3200
× g for 20 min at 4C and the organic solvents were removed from
the resulting pellet by the addition of 10 ml of ethanol. The
mixture was centrifuged again at 3200 × g for 20 min at 4C, the
supernatant was removed and the pellet was dried for 4 h at 40C.
The dried pellet was resuspended in 1 ml of 100 mM Tris HCI,
pH 8.0, containing 1 mM CaCl2 and subjected to protein digestion
with 0.1 kallikrein units (KU) of pronase (protease from
Streptomyces griseus, Calbiochem). The pronase solution was
preincubated for 30 min at 60C to eliminate any glycosidase
activity. Digestion was carried out for 72 h at 60C by adding
equal amounts of pronase at 24 h intervals. The sample was then
adjusted to 150 mM NaCl and 10 mM MgCl2, and DNA digestion
was accomplished by incubating the sample with 400 KU of
DNase I (EC 3.1.21.1, Boehringer Mannheim) for 16 h at 37C.
The concentration of CaCl2 was adjusted to 1 mM and the
reaction was stopped by adding 0.1 KU of pronase for 24 h at
60C. The pH was adjusted to 10.0–11.0 by adding 10 mM NaOH
and glycans were subjected to elimination reaction in the presence
of 1 M NaBH4 for 16 h at 45C (Roden et al., 1972). Samples
were then neutralized with 50% (volume/volume) acetic acid.
Glycans were separated from degradation products by gel
filtration (Sephadex G-25 column, 0.6 × 25 cm) and eluted with
10 mM pyridine acetate, pH 5.0. Fractions of 0.5 ml were
collected and analyzed for neutral hexoses (Shields and Burnett,
1960) and uronic acids (Bitter and Muir, 1962) content.
HPLC analysis
Fractionation of glycans was performed by HPLC (Bio-Rad) with
a Bio-Gel TSK 40XL gel filtration column (300 × 7.8 mm).
Elution was carried out with 7 mM Tris, pH 7.4, containing
200 mM NaCl, at a flow rate of 0.3 ml/min. The apparent
molecular weight of the glycans was estimated by using the
following molecular weight markers: HA, 225 kDa (Sigma);
chondroitin sulfates, 19.7–101.6 kDa (Sigma); and heparins
4.44–11 kDa (Sigma). The molecular mass of these markers was
estimated by analytical ultracentrifugation, as previously de-
scribed (Papakonstantinou and Misevic, 1993). During HPLC gel
filtration, absorbance was monitored at 206 nm or 232 nm with
an ultraviolet monitor (Bio-Rad, model 1706) and a refractive
index monitor (Bio-Rad, model 1755).
Characterization of HA-340 with GAG-degrading enzymes
Lyophilized HA-340 (10 µg of uronic acids) were incubated in a
final volume of 20 µl as follows: (1) heparinase: samples were
dissolved in 100 mM sodium acetate, pH 7.0, containing 3 mM
CaCl2 and incubated with 4 × 10–4 units of heparin Iyase (EC
4.2.2.7, Flavobacterium heparinum, Seikagaku) for 15 h at 35C;
(2) heparitinase: samples were dissolved as above and incubated
with 4 × 10–4 units of heparan sulfate lyase (EC 4.2.2.8,
Flavobacterium heparinum, Seikagaku) for 16 h at 43C; (3)
chondroitinase ABC: samples were dissolved in 100 mM Tris
HCI, pH 8.0, containing 50 mM sodium acetate and incubated
with 5 × 10–4 unit of chondroitin ABC Iyase (EC 4.2.2.4, Proteus
vulgaris, Sigma) for 16 h at 37C; (4) keratanase: samples were
dissolved in 50 mM Tris HCI, pH 7.4, and incubated with 0.1
units of keratan sulfate endo-1,4-,β-galactosidase (EC 3.2.10.3
Pseudomonas species, Sigma) for 16 h at 37C; and (5)
hyaluronidase: samples were dissolved in 20 mM sodium acetate,
buffered with acetic acid to pH 5.0, and incubated with 5 units of
hyaluronate lyase (EC 4.2.2.1, Streptomyces hyalurolyticus,
Sigma) for 6 h at 60C. Incubation times and enzyme concentra-
tions used were those required for the complete degradation of
their respective standard substrates, as estimated by preliminary
investigation. In this preliminary study, the standard GAGs
(50 µg) chondroitin sulfate A (bovine trachea), chondroitin
sulfate B (porcine skin), chondroitin sulfate C (shark cartilage),
HA (bovine trachea), keratan sulfate (bovine cornea), heparan
sulfate (bovine intestinal mucosa), and heparin (all from Sigma)
were treated with all the above mentioned GAG-degrading
enzymes following appropriate incubation procedures. Sub-
strates incubated separately with their respective buffers served
as controls. Digestion was initially evaluated by PAGE as
previously described (Papakonstantinou and Misevic, 1993) and
then by HPLC gel filtration with continuous recording of the
absorbance at 206 and 232 nm and of the refractive index.
Digestion (percent) was calculated from the ratios of the area
under the curve of enzyme treated substrates over the area under
the curve of buffer treated substrates of (1) the absorbance at
206 nm, (2) the absorbance at 232 nm, and (3) the refractive
index. All glycosaminoglycan-degrading enzymes used could
completely digest their respective specific substrates. However,
3% of HA and 2% of chondroitin sulfate A could not be digested
by their respective specific enzymes, which may be attributed to
impurities.
Proliferation assay
Quiescent subconfluent VSMC (80% cell density starved for 48 h
at 0.1% FCS) were pretreated for 2 h with various concentrations
of HA-340. PDGF-BB (10 ng/ml) and [3H]-thymidine (0.5 µCi/
ml) were then added simultaneously to the culture medium and
mitogenic cell activation was assessed after 36 h of further
incubation by measuring the amount of [3H]-thymidine incorpo-
rated into newly synthesized DNA, as described previously (Roth
et al., 1996b). Unstimulated cells were used as controls for each
time point.
Chemotaxis, migration, and invasion assays
Cells (104 cells/ml) were seeded onto cell-permeable filters
(pore-size 8 µm) of invasion chambers (Boyden-chamber-sys-
tems; Collaborative Biolabs, Becton Dickinson), and incubated
for 24 h at 37C prior to the addition of the stimuli. PDGF-BB
(10 ng/ml) and/or various concentrations of HA-340 or HA
(225 kDa, Sigma) were added either to the lower or the upper
compartment. Chambers were incubated for additional 24 h
(37C, 5% CO2) before the filters were removed. Cells adherent
to the upper side were removed and cells on the lower side of the
membranes were fixed with 0.1 ml of 4% paraformaldehyde in
PBS and stained with Hoechst dye for 2 min. Chemotaxis or
migration were assessed by counting the cells that appeared on the
lower side of the filters by immunofluorescence microscopy
(100×). In all cases, three randomly selected areas (1 × 1 mm2)
were counted per filter. For the invasion studies, the same
approach was used with the modification that the filters were
precoated with a reconstituted BM (Matrigel, Collaborative
Biolabs).
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Gelatin zymography
The gelatinolytic activity of secreted MMP-2 was determined
using gelatin zymography analysis under denaturing but nonre-
ducing conditions, as described previously (Roth et al., 1996a).
In brief, quiescent subconfluent cells were challenged with
PDGF-BB (10 ng/ml), HA-340, HA (225 kDa, Sigma), or a
combination of one of the glycans with PDGF. Cell culture media
were collected at 24 h after addition of the respective stimuli, and
aliquots (10 µl) were run on a 8% SDS/polyacrylamide gel
containing 0.1% gelatin (25 mA, 2 h, room temperature). Gels
were then equilibrated in 2.5% Triton X-100 for 1 h and
subsequently incubated in enzyme buffer (50 mM Tris-HCl, pH
7.3, containing 200 mM NaCl, 5 mM CaCl2, and 0.02% Brij 35)
for 18 h at 37C. Bands of enzymatic activity were visualized by
negative staining with standard Coomassie brilliant blue dye
solution. Molecular sizes of bands displaying enzymatic activity
were characterized by comparison to prestained standard proteins
(Bio-Rad) and to purified MMP-2 (Anawa Trading, Wangen).
MMP-2 inhibitor
The ability of VSMC to invade reconstituted BM was also studied
in the presence of the dipeptide analog hydroxamic acid,
HONHCOCH2CH(i-Bu)CO-L-Trp-NHMe (GM6001), a spe-
cific MMP inhibitor (Grobelny et al., 1992 ), which was a gift
from Dr. David Leppert, Department of Research, Kantonsspital
Basel. GM6001 was dissolved in PBS and sterilized by filtration.
Cells were incubated for 30 min with 10–8 to 10–6 M GM6001
before the addition of HA-340 and proceeded as described above
in the invasion assays.
Statistical analysis
Means ± SE were calculated on the basis of at least four different
VSMC cell lines and of all biopsy specimens obtained. Determi-
nations were always made in triplicate. Statistical analysis of
thymidine incorporation, invasion, chemotaxis, and HA-340
expression was performed using Student’s unpaired t-test.
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